Foundations Investment Advisors LLC Grows Stake in Danaher Co. (NYSE:DHR)

Foundations Investment Advisors LLC lifted its stake in Danaher Co. (NYSE:DHR) by 41.8% in the 4th quarter, Holdings Channel.com reports. The firm owned 2,321 shares of the conglomerate’s stock after buying an additional 684 shares during the quarter. Foundations Investment Advisors LLC’s holdings in Danaher were worth $533,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of DHR. Coronation Fund Managers Ltd. grew its holdings in shares of Danaher by 29.9% during the second quarter. Coronation Fund Managers Ltd. now owns 6,389 shares of the conglomerate’s stock valued at $1,596,000 after buying an additional 1,470 shares during the last quarter. Quarry LP boosted its stake in Danaher by 250.6% during the 2nd quarter. Quarry LP now owns 298 shares of the conglomerate’s stock valued at $74,000 after purchasing an additional 213 shares during the last quarter. Cetera Investment Advisers raised its stake in shares of Danaher by 6.5% in the second quarter. Cetera Investment Advisers now owns 130,209 shares of the conglomerate’s stock worth $32,533,000 after purchasing an additional 7,986 shares during the last quarter. Sanctuary Advisors LLC bought a new position in shares of Danaher during the second quarter valued at $19,512,000. Finally, Healthcare of Ontario Pension Plan Trust Fund boosted its position in shares of Danaher by 21.4% during the second quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 45,434 shares of the conglomerate’s stock valued at $11,352,000 after buying an additional 8,006 shares during the last quarter. Institutional investors own 79.05% of the company’s stock.

Analyst Ratings Changes

DHR has been the topic of several research analyst reports. UBS Group lowered their target price on shares of Danaher from $309.00 to $305.00 and set a “buy” rating on the stock in a research note on Wednesday, October 23rd. TD Cowen raised their target price on shares of Danaher from $310.00 to $315.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Barclays decreased their target price on shares of Danaher from $275.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday. Wells Fargo & Company dropped their price target on Danaher from $280.00 to $240.00 and set an “equal weight” rating on the stock in a research note on Thursday. Finally, JPMorgan Chase & Co. reduced their price objective on Danaher from $310.00 to $300.00 and set an “overweight” rating for the company in a research report on Tuesday. Six research analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $278.00.

Danaher Trading Down 0.3 %

DHR stock opened at $223.16 on Friday. Danaher Co. has a twelve month low of $221.34 and a twelve month high of $281.70. The stock has a market capitalization of $161.19 billion, a price-to-earnings ratio of 42.59, a price-to-earnings-growth ratio of 4.43 and a beta of 0.83. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The firm’s fifty day simple moving average is $235.89 and its two-hundred day simple moving average is $253.45.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share for the quarter, hitting analysts’ consensus estimates of $2.14. Danaher had a net margin of 16.39% and a return on equity of 10.62%. During the same period last year, the company posted $2.09 EPS. As a group, analysts anticipate that Danaher Co. will post 7.5 earnings per share for the current year.

Danaher Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Friday, December 27th will be issued a dividend of $0.27 per share. This represents a $1.08 dividend on an annualized basis and a yield of 0.48%. The ex-dividend date is Friday, December 27th. Danaher’s payout ratio is currently 20.61%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.